UPC_OUT_1 [2025-04-04 10:18:05 -0400] 3547 Bytes | 863 tokens | Cum: 863 tkns (10.79% of 8k)
==========================================================================

We're scouting for winners today. Its 10:18:04 AM on Fri Apr 04, 2025 -0400 and I'm looking at Universe Pharmaceuticals (UPC) up to 3.4821 from 2.88

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

--- COMPANY PROFILE ---
Company: Universe Pharmaceuticals (UPC)
IPO: 2021-03-23 (4 Years Ago)
Market Cap: $1,088,599
Shares Outstanding: 180,000
Exchange: XNAS
Description: Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Here’s the first list of news for Universe Pharmaceuticals:

C1 - Mar-20-25 08:42AM - Universe Pharmaceuticals to conduct share consolidation
C2 - Mar-20-25 08:42AM 08:30AM - Universe Pharmaceuticals INC Announces Share Consolidation
C3 - Feb-25-25 04:10PM - Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report
C4 - Feb-03-25 04:10PM - Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request
C5 - Dec-10-24 05:00PM - Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)
C6 - Dec-09-24 07:00AM - Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
C7 - Nov-13-24 08:00AM - Universe Pharmaceuticals INC Announces Share Consolidation
C8 - Nov-01-24 04:00PM - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Prior AI Reports for UPC:
1. 2025-03-25 – Score: 20 – Target: 5.3000 – Highs: 5.6400 / 4.9700 / 5.36
universe-pharmaceuticals-faces-bleak-projections-amidst-steep-sales-decline
2. 2025-03-24 – Score: 15 – Target: 4.3000 – Highs: 4.3900 / 5.6400 / 4.97
universe-pharmaceuticals-declining-sales-performance-concerns-loom

(Note: Highs = Same day / 2nd day / 3rd day)

GUIDELINES FOR AI:
==============

1) You are the **AI analyst-investigator**. I am **ScanScor**, a unified document retrieval and reporting system.
Your role is to examine all available company data and draw sound conclusions.

2) To request additional information, refer to any listed documents using their reference codes.
The company under analysis is: Universe Pharmaceuticals (UPC).

3) As the analysis proceeds, continue reviewing documents until you feel confident in your judgment.
When ready, you will:
- Write a brief summary
- Generate a headline
- Assign a MARKET_SCORE[XX]
- Set a PRICE_TARGET[XX]

4) For now, restrict your response to just **three tokens**.
To request a document, reply with its reference code(s), such as:
- `C1`, `C2`, `C3`, etc.
- To load more documents, reply with: `NEX`

News articles, SEC filings, and key metrics will be revealed in subsequent prompts.
Stay focused. Gather evidence. Continue until your conclusions are clear.

UPC_OUT_3 [2025-04-04 10:18:09 -0400] 1108 Bytes | 312 tokens | Cum: 1178 tkns (14.72% of 8k)
==========================================================================

Showing C3 (chunk 1 of 5): C3:
**Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report**
Date: Feb-25-25 04:10PM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/02/25/3032444/0/en/Universe-Pharmaceuticals-INC-Receives-Staff-Determination-Notice-from-Nasdaq-Related-to-Delayed-Annual-Report.html

February 25, 2025 16:10 ET| Source:Universe Pharmaceuticals INC.Universe Pharmaceuticals INC.

Ji’an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the Company received a staff determination notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is delinquent in filing its Annual Report on Form 20-F for the fiscal

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

UPC_OUT_5 [2025-04-04 10:18:10 -0400] 883 Bytes | 241 tokens | Cum: 1488 tkns (18.60% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-01T17:05:47Z - 12 Health Care Stocks Moving In Tuesday's Intraday Session - bioAffinity Technologies (NASDAQ:BIAF),...
A2 - 2025-03-20T13:18:00Z - Universe Pharmaceuticals Plans To Effect Share Consolidation...
A3 - 2025-03-20T12:33:22Z - Universe Pharmaceuticals INC Announces Share Consolidation...
A4 - 2025-03-20T12:42:57Z - Universe Pharmaceuticals to conduct share consolidation (NASDAQ:UPC)...
A5 - 2025-03-20T12:39:35Z - Universe Pharmaceuticals INC Announces Share Consolidation...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

UPC_OUT_7 [2025-04-04 10:18:18 -0400] 1098 Bytes | 329 tokens | Cum: 1819 tkns (22.74% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**12 Health Care Stocks Moving In Tuesday's Intraday Session - bioAffinity Technologies (NASDAQ:BIAF), CARISMA Therapeutics (NASDAQ:CARM)**Date: 2025-04-01Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/04/44591128/12-health-care-stocks-moving-in-tuesdays-intraday-sessionGainers Reshape Lifesciences RSLS stock moved upwards by 488.1% to $2.12 during Tuesday's regular session. The market value of their outstanding shares is at $7.0 million. bioAffinity Technologies BIAF stock increased by 236.5% to $0.87. The market value of their outstanding shares is at $13.6 million. As per the news, the Q4 earnings report came out yesterday. Alaunos Therapeutics TCRT shares moved upwards by 55.1% to $2.28. The market value of their outstanding shares is at $3.6 million. Nutex Health NUTX shares moved upwards by 53.55% to $72.

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

UPC_OUT_9 [2025-04-04 10:18:19 -0400] 1034 Bytes | 290 tokens | Cum: 2251 tkns (28.14% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-11-01T20:00:00Z - Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
B2 - 2024-02-20T18:21:11Z - Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B3 - 2024-02-20T13:09:16Z - Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
B4 - 2024-01-08T18:36:30Z - Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
B5 - 2023-08-04T12:30:00Z - Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares
B6 - 2023-07-27T14:15:00Z - Universe Pharmaceuticals INC Announces Share Consolidation

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

UPC_OUT_11 [2025-04-04 10:18:23 -0400] 1100 Bytes | 280 tokens | Cum: 2533 tkns (31.66% of 8k)
==========================================================================

Showing B3 (chunk 1 of 2): B3:
**Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/02/37210416/why-discover-financial-services-shares-are-trading-higher-by-around-11-here-are-20-stocks-moving-preShares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading.
Capital One Financial Corp (NYSE: COF) announced its plans to purchase Discover Financial Services, marking a pivotal $35.3 billion all-stock transaction.
As per the terms of the deal, Discover shareholders are slated to receive 1.0192 shares of Capital One for every share they hold, translating to a 26% premium over Discover's last closing price.
Discover Financial Services shares jumped 11.2% to $122.88 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gain

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

UPC_OUT_13 [2025-04-04 10:18:24 -0400] 238 Bytes | 59 tokens | Cum: 2710 tkns (33.88% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

UPC_OUT_15 [2025-04-04 10:18:41 -0400] 3921 Bytes | 956 tokens | Cum: 3669 tkns (45.86% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+------------------------+------------------------+
| Volume: 63,356 | Perf Month: -32.26% | Option/Short: No / Yes | Sales Y/Y TTM: -22.33% |
+---------------------+-----------------------+------------------------+------------------------+
| Avg Volume: 317.14K | Perf Quarter: -87.06% | Short Float: 1.03% | ROE: -50.22% |
+---------------------+-----------------------+------------------------+------------------------+
| Rel Volume: 1.56 | Index: - | Short Ratio: 0.01 | ROI: -64.36% |
+---------------------+-----------------------+------------------------+------------------------+
| RSI (14): 35.19 | Market Cap: 0.72M | Short Interest: 0.00M | Sales Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| ATR (14): 1.05 | Shs Outstand: 3.65M | Beta: 1.63 | EPS Surprise: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA20: -20.52% | Shs Float: 0.21M | Sales Q/Q: -30.23% | P/E: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA50: -53.77% | Inst Own: 6.51% | Sales past 5Y: - | Earnings: - |
+---------------------+-----------------------+------------------------+------------------------+
| SMA200: -99.48% | Insider Own: 1.60% | Employees: - | |
+---------------------+-----------------------+------------------------+------------------------+
| Perf Week: -31.90% | Insider Trans: 0.00% | Debt/Eq: 0.24 | |
+---------------------+-----------------------+------------------------+------------------------+

The next section covers any insider trading if any are accessible.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): N/A
Net Income: N/A
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 3.49
Average Volume: 87229.72
30-Day High: 5.512
30-Day Low: 2.85
No detailed financial data available.
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Do not say you lacked information. Save that for the final survey.

Now complete this report with the following:

1) Brief Summary: Explain your findings in one well-worded paragraph.

2) MARKET_SCORE: Estimate a number between 1 and 100 to represent the likelihood of an upward price move over the next day, week, or longer. Use the format: MARKET_SCORE[XX]
Weigh all relevant data —- news, SEC filings, fundamentals, and metrics —- and assign each element appropriate weight to calculate a general MARKET_SCORE[XX].
This score should be grounded in objective reasoning and guided by your analytical judgment.
XX must be a whole number between 1 and 100.

3) PRICE_TARGET: The current price of {ticker} is {current_price}.
If you believe it’s likely to rise, calculate a reasonable new price target.
For example, if you expect a 50% increase, say: PRICE_TARGET[{increased_price}]
You are encouraged to reference prior price performance when making this estimate.

4) AI_RPT_HEADLINE: Provide a thought-provoking headline (8–12 words) summarizing the situation.
Examples:
- AI_RPT_HEADLINE[{co_name} makes news with FDA approval fueling high investor optimism]
- AI_RPT_HEADLINE[Declining sales plague {ticker}, worsening an already negative outlook]

Return only:
1) Brief Summary
2) MARKET_SCORE[]
3) PRICE_TARGET[]
4) AI_RPT_HEADLINE[]

UPC_OUT_17 [2025-04-04 10:18:42 -0400] 687 Bytes | 169 tokens | Cum: 4199 tkns (52.49% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More news listings
-> X2 <- More SEC filing extractions (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider trading extractions (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this company
-> X8 <- Something altogether different (explain...)

UPC_IN_19 [2025-04-04 10:18:43 -0400] 126 Bytes | 29 tokens | Cum: 4258 tkns (53.23% of 8k)
==========================================================================

====================================
[2025-04-04 10:18:43] # Analysis Completed
Elapsed Time: 38.99 seconds